Vaccine News and Research

Latest Vaccine News and Research

New data on Soliris for PNH treatment to be presented at ASH Annual Meeting

New data on Soliris for PNH treatment to be presented at ASH Annual Meeting

New Yorker examines global TB diagnostic challenges

New Yorker examines global TB diagnostic challenges

First Edition: November 8, 2010

First Edition: November 8, 2010

Research on immune system may help develop improved vaccines for cancer

Research on immune system may help develop improved vaccines for cancer

New findings could help scientists devise optimal therapies for Friedreich's ataxia

New findings could help scientists devise optimal therapies for Friedreich's ataxia

Scientists identify genes that enable some immune systems to halt HIV; finding could spur drug, vaccine development

Scientists identify genes that enable some immune systems to halt HIV; finding could spur drug, vaccine development

GeoVax receives $244,500 grant under QTDP program for HIV/AIDS vaccine development

GeoVax receives $244,500 grant under QTDP program for HIV/AIDS vaccine development

Inviragen to present data on CHIKV vaccine at ASTMH meeting

Inviragen to present data on CHIKV vaccine at ASTMH meeting

Researchers take first step towards understanding of rare skin cancer

Researchers take first step towards understanding of rare skin cancer

Sanofi Pasteur's dengue vaccine enters phase III trial in Australia

Sanofi Pasteur's dengue vaccine enters phase III trial in Australia

Research Roundup: Basing insurance on results, not cost; Americans skeptical of public health efforts; seniors' comprehensive care

Research Roundup: Basing insurance on results, not cost; Americans skeptical of public health efforts; seniors' comprehensive care

Antigenics awarded $424,720 grant under QTDP program

Antigenics awarded $424,720 grant under QTDP program

HPV vaccine enjoys wide support from medical and public health communities

HPV vaccine enjoys wide support from medical and public health communities

World's most clinically advanced dengue vaccine candidate enters first phase 3 clinical study

World's most clinically advanced dengue vaccine candidate enters first phase 3 clinical study

FIP Annual Meeting to improve global health through advances in pharmaceutical sciences

FIP Annual Meeting to improve global health through advances in pharmaceutical sciences

Combination of DC-CIK and stem cell therapy effective to prevent cancer recurrence after surgery

Combination of DC-CIK and stem cell therapy effective to prevent cancer recurrence after surgery

Lentigen awarded $1.23M grant under Patient Protection and Affordable Care Act

Lentigen awarded $1.23M grant under Patient Protection and Affordable Care Act

Afinitor tablets decrease size of SEGA associated with tuberous sclerosis

Afinitor tablets decrease size of SEGA associated with tuberous sclerosis

Aduro receives $442,000 grant under QTDP program to support Listeria-based immunotherapy platform

Aduro receives $442,000 grant under QTDP program to support Listeria-based immunotherapy platform

PharmAthene closes public offering of common stock

PharmAthene closes public offering of common stock

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.